溶酶体贮积病的早期产前诊断:酶学与分子分析
该研究报告了中国大陆一家中心4年间47例溶酶体贮积病(LSD)妊娠的早期产前诊断经验,采用未培养绒毛膜绒毛(CV)样本的酶学测定和/或分子研究。47例胎儿中23例(48.9%)正常、13例(27.7%)为携带者、11例(23.4%)确诊患病;黏多糖贮积症II型最常见,其次为庞贝病和异染性脑白质营养不良。结论认为基于未培养CV的不同酶学特性,MPS II和庞贝病应采用不同产前诊断策略,酶学与分子研究结合可提高LSD产前诊断可靠性。
要点
- 47例LSD妊娠产前诊断中,23例(48.9%)正常、13例(27.7%)携带者、11例(23.4%)患病。
- MPS II最常见,其次为庞贝病和异染性脑白质营养不良。
- MPS II患病胎儿酶活性1.4%–6.7%,正常胎儿72%–240.4%。
核心结论
- 基于未培养CV的不同酶学特性,MPS II和庞贝病应采用不同的产前诊断策略。
- 未培养CV的酶学测定与分子研究结合可提高LSD产前诊断的可靠性。
研究设计与样本
- 回顾性报告中国大陆一家中心4年间47例LSD妊娠的早期产前诊断经验。
- 产前研究采用未培养绒毛膜绒毛43例、羊水2例、脐带血2例,进行酶学和/或分子研究。
主要发现
- 47例胎儿中23例(48.9%)正常、13例(27.7%)为携带者、11例(23.4%)确诊患病。
- 本队列中黏多糖贮积症II型最常见,其次为庞贝病,再次为异染性脑白质营养不良。
- 17例MPS II中,4例患病胎儿MPS II酶活性表达水平为1.4%–6.7%,13例正常胎儿酶活性水平为72%–240.4%。
- 7例庞贝病中,3例正常胎儿庞贝病酶活性表达水平分别为20%、38.8%和77.3%,4例携带者妊娠酶活性水平分别为17.5%、17.5%、33.4%和13.8%。
临床怎么用
- 作者认为基于未培养CV的不同酶学特性,MPS II和庞贝病应采用不同的产前诊断策略,酶学与分子研究结合可提高LSD产前诊断的可靠性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To report the 4-year experience of early prenatal diagnosis of lysosomal storage disorders (LSDs) at a center in mainland China. METHOD: Forty-seven pregnancies affected with LSDs were assed using enzymes and/or molecular studies. Prenatal studies were performed on 43 uncultured chorionic villi (CV) samples, two amniotic fluid samples, and two umbilical cord blood samples. RESULTS: Of the 47 fetuses, 23 (48.9%) were determined to normal, 13 (27.7%) to be carriers, and 11 (23.4%) diagnosed as affected. In this cohort, mucopolysaccharidoses (MPS) type II was the most common LSD, followed by Pompe disease and then metachromatic leucodystrophy. In the 17 MPS II cases, the four affected fetuses showed MPS II enzyme activity expression levels of 1.4% to 6.7%, while the enzyme activity levels of the 13 normal fetuses ranged from 72% to 240.4%. In the seven Pompe cases, three fetuses were normal with Pompe enzyme activity expression levels of 20%, 38.8%, and 77.3%, while four carrier pregnancies showed enzyme activity levels of 17.5%, 17.5%, 33.4%, and 13.8%, respectively. CONCLUSION: Based on different enzyme properties in uncultured CV, different prenatal diagnostic strategies should be adopted for MPS II and Pompe disease. Combining enzyme assay and molecular studies in uncultured CV improves the reliability of prenatal diagnosis of LSDs.
引用
- Li D, Lin Y, Huang Y, et al. Early prenatal diagnosis of lysosomal storage disorders by enzymatic and molecular analysis. Prenat Diagn. 2018. PMID: 29966168. doi:10.1002/pd.5329
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。